38 Result(s)
within
Olivier Cussenot
Urology
-
Article
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?
A re-transurethral resection of the bladder (re-TURB) is a well-established approach in managing non-muscle invasive bladder cancer (NMIBC) for various reasons: repeat-TURB is recommended for a macroscopically in...
-
Article
Eliciting men’s preferences for decision-making relative to treatments of localized prostate cancer with a good or moderate prognosis
In diseases where there is no real consensus regarding treatment modalities, promoting shared decision-making can contribute to improving safety and quality of care. This is the case in low- or intermediate-ri...
-
Article
Incidence of bladder cancer in neuro-urological patients in France: a nationwide study
The purpose of this study was to evaluate the incidence of bladder cancer (BCa) in patients with the main neurological diseases that induce neurogenic lower urinary tract dysfunction, namely, multiple sclerosi...
-
Article
Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: are they the same tumors?
The aim of our study was to evaluate and compare the expression of different immunohistochemical markers in Bladder Carcinomas (BC) in patients with Neurogenic Bladder (NB) and Urinary Schistosomiasis (US) inf...
-
Article
A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology
To establish whether the expression of markers of cell differentiation (CK7, CK14, CK20, GATA3), apoptosis (p53), proliferation (Ki67, STAG2) and peri-tumoural lymphocytes (CD3, CD8), provides specific informa...
-
Article
Open AccessPD-L1 (SP142) testing is concordant between Benchmark Ultra and Bond-III stainers
Atezolizumab is an inhibitor of programmed death-ligand 1 (PD-L1), used to treat advanced or metastatic bladder cancer, and in trials for non-invasive disease. In order to be eligible for treatment, patients r...
-
Article
Open AccessPathological reporting of cystectomy lymph nodes: a retrospective analysis of experience in Paris
Pathological evaluation of pelvic lymph node (LN) dissection (PLND) is important for management of cystectomy patients. However, challenges such as unclear interobserver variability of LN counting remain. Here...
-
Article
Open AccessAssessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up
To assess the performance of the Xpert Bladder Cancer (BC) Monitor during the follow-up of patients with non-muscle invasive bladder cancer (NMIBC).
-
Chapter
Irreversible Electroporation (IRE) for Prostate Cancer
Electroporation is a novel ablative technique with the potential to overcome the main disadvantages of other ablative methods. It utilizes electric pulses, traveling between two or more electrodes, to create “...
-
Article
Impact of sodium 18F-fluoride PET/CT, 18F-fluorocholine PET/CT and whole-body diffusion-weighted MRI on the management of patients with prostate cancer suspicious for metastasis: a prospective multicentre study
To compare the impact of 18F-sodium-fluoride (NaF) PET/CT, 18F-fluorocholine (FCH) PET/CT and diffusion-weighted whole-body MRI (DW-MRI) on the management of patients with prostate cancer (PCa) suspicious for ...
-
Article
Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy
Previous studies of the cell cycle progression (CCP) score in surgical specimens of prostate cancer (PCa) in patients treated by radical prostatectomy (RP) demonstrated significant association with time to bio...
-
Article
Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma
To review the contemporary data on the role of lymph node dissection (LND) at the time of radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC).
-
Article
Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway
A few preliminary studies have suggested a link between some genetics variants and benign prostatic hyperplasia (BPH). Our goal was to study the link between a set of single nucleotide polymorphisms (SNPs) imp...
-
Article
Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy
To evaluate the use of multiparametric MRI (mp MRI) parameters in order to predict prostate cancer aggressiveness as defined by pathological Gleason score or molecular markers in a cohort of patients defined w...
-
Article
Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric study
To assess whether non-suspicious multiparametric magnetic-resonance imaging (mpMRI) was associated with no cancer or indolent prostate cancer (PCa) in subsequent biopsies.
-
Article
Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers
Low-risk prostate cancer is found in about half of newly diagnosed men subjected to PSA screening.
-
Article
Functional magnetic resonance imaging and molecular pathology at the crossroad of the management of early prostate cancer
According to recent reports from randomized studies comparing radical treatment or watchful waiting, the outcome of localized prostate cancer remains uncertain at individual level. It is especially true for th...
-
Article
Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy
To evaluate the influence of preoperative factors on the survival of patients diagnosed with upper tract urothelial carcinoma (UTUC) who underwent a radical nephroureterectomy (RNU).
-
Article
Open AccessDetection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma
Bladder carcinoma (B-TCC) is the fifth most prevalent carcinoma in the United States (US) or Europe. In addition, B-TCC is the most expensive carcinoma per patient between diagnosis and death, because of its 5...
-
Article
Charlson score as a single pertinent criterion to select candidates for active surveillance among patients with small renal masses
The aim of the study was to assess the outcome after nephron-sparing surgery (NSS) of patients with small renal masses (SRMs) who would have been eligible for active surveillance (AS).
